ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Detroit, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Detroit, MI, USA:

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

older who are receiving relugolix or leuprolide acetate for their prostate cancer or as adjunct to radiation therapy with a treatme...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Myovant Sciences

Royal Oak, Michigan, United States and 107 other locations

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...

Enrolling
Prostatic Disease
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Drug: Gedatolisib
Drug: Darolutamide

Phase 1, Phase 2

Celcuity Inc

Detroit, Michigan, United States of America and 12 other locations

The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer
Radiation: Radium 223
Drug: Docetaxel

Phase 1

Tufts University
Tufts University

Detroit, Michigan, United States and 3 other locations

Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...

Enrolling
Prostate Cancer
Other: No Treatment
Drug: Saruparib (AZD5305)

Phase 1

AstraZeneca
AstraZeneca

Detroit, Michigan, United States and 16 other locations

This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also de...

Enrolling
Prostate Cancer
Device: Oncotype Dx Genomic Prostate Score (GPS)
Device: Prolaris
University of Michigan Rogel Cancer Center

Detroit, Michigan, United States and 6 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Detroit, Michigan, United States and 53 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Arvinas
Arvinas

Detroit, Michigan, United States and 22 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Ann Arbor, Michigan, United States and 11 other locations

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Enrolling
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

Troy, Michigan, United States and 27 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Detroit, Michigan, United States and 131 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems